OpenEvidence reportedly considers raising $200M at a $20B valuation, marking a rapid ascent for the AI medical platform used by over 40% of US physicians.
The post OpenEvidence reportedly eyes $200M raise at $20B valuation, signaling AI healthcare’s breakneck growth appeared first on Crypto Briefing.